Literature DB >> 20035439

Role of nutritional zinc in the prevention of osteoporosis.

Masayoshi Yamaguchi1.   

Abstract

Zinc is known as an essential nutritional factor in the growth of the human and animals. Bone growth retardation is a common finding in various conditions associated with dietary zinc deficiency. Bone zinc content has been shown to decrease in aging, skeletal unloading, and postmenopausal conditions, suggesting its role in bone disorder. Zinc has been demonstrated to have a stimulatory effect on osteoblastic bone formation and mineralization; the metal directly activates aminoacyl-tRNA synthetase, a rate-limiting enzyme at translational process of protein synthesis, in the cells, and it stimulates cellular protein synthesis. Zinc has been shown to stimulate gene expression of the transcription factors runt-related transcription factor 2 (Runx2) that is related to differentiation into osteoblastic cells. Moreover, zinc has been shown to inhibit osteoclastic bone resorption due to inhibiting osteoclast-like cell formation from bone marrow cells and stimulating apoptotic cell death of mature osteoclasts. Zinc has a suppressive effect on the receptor activator of nuclear factor (NF)-kappaB ligand (RANKL)-induced osteoclastogenesis. Zinc transporter has been shown to express in osteoblastic and osteoclastic cells. Zinc protein is involved in transcription. The intake of dietary zinc causes an increase in bone mass. beta-Alanyl-L: -histidinato zinc (AHZ) is a zinc compound, in which zinc is chelated to beta-alanyl-L: -histidine. The stimulatory effect of AHZ on bone formation is more intensive than that of zinc sulfate. Zinc acexamate has also been shown to have a potent-anabolic effect on bone. The oral administration of AHZ or zinc acexamate has the restorative effect on bone loss under various pathophysiologic conditions including aging, skeletal unloading, aluminum bone toxicity, calcium- and vitamin D-deficiency, adjuvant arthritis, estrogen deficiency, diabetes, and fracture healing. Zinc compounds may be designed as new supplementation factor in the prevention and therapy of osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035439     DOI: 10.1007/s11010-009-0358-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  115 in total

1.  Effect of the new zinc compound beta-alanyl-L-histidinato zinc on bone metabolism in elderly rats.

Authors:  M Yamaguchi; K Ozaki
Journal:  Pharmacology       Date:  1990       Impact factor: 2.547

2.  Beta-alanyl-L-histidinato zinc prevents the toxic effect of aluminium on bone metabolism in weanling rats.

Authors:  M Yamaguchi; K Ozaki
Journal:  Pharmacology       Date:  1990       Impact factor: 2.547

3.  Albumin regulates Runx2 and alpha1 (I) collagen mRNA expression in osteoblastic cells: comparison with insulin-like growth factor-I.

Authors:  Koichi Ishida; Masayoshi Yamaguchi
Journal:  Int J Mol Med       Date:  2005-10       Impact factor: 4.101

4.  Prolonged administration of beta-alanyl-L-histidinato zinc prevents bone loss in ovariectomized rats.

Authors:  M Yamaguchi; S Kishi
Journal:  Jpn J Pharmacol       Date:  1993-10

5.  Ovariectomy, dietary zinc, and bone metabolism in retired breeder rats.

Authors:  S S Sherman; J C Smith; J D Tobin; J H Soares
Journal:  Am J Clin Nutr       Date:  1989-06       Impact factor: 7.045

6.  Osteopenia and male-specific sudden cardiac death in mice lacking a zinc transporter gene, Znt5.

Authors:  Koichi Inoue; Koichi Matsuda; Makoto Itoh; Hiroshi Kawaguchi; Hitonobu Tomoike; Teruhiko Aoyagi; Ryozo Nagai; Masatsugu Hori; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Hum Mol Genet       Date:  2002-07-15       Impact factor: 6.150

7.  Effect of beta-alanyl-L-histidinato zinc on differentiation of osteoblastic MC3T3-E1 cells: increases in alkaline phosphatase activity and protein concentration.

Authors:  M Hashizume; M Yamaguchi
Journal:  Mol Cell Biochem       Date:  1994-02-09       Impact factor: 3.396

8.  Studies of marginal zinc deprivation in rhesus monkeys. V. Fetal and infant skeletal effects.

Authors:  J C Leek; J B Vogler; M E Gershwin; M S Golub; L S Hurley; A G Hendrickx
Journal:  Am J Clin Nutr       Date:  1984-12       Impact factor: 7.045

9.  Preventive effect of zinc acexamate administration in streptozotocin-diabetic rats: Restoration of bone loss.

Authors:  Masayoshi Yamaguchi; Satoshi Uchiyama
Journal:  Int J Mol Med       Date:  2003-11       Impact factor: 4.101

10.  Great increase in bone 66 kDa protein and osteocalcin at later stages with healing rat fractures: effect of zinc treatment.

Authors:  Aki Igarashi; Masayoshi Yamaguchi
Journal:  Int J Mol Med       Date:  2003-02       Impact factor: 4.101

View more
  76 in total

1.  Effects of silica and zinc oxide doping on mechanical and biological properties of 3D printed tricalcium phosphate tissue engineering scaffolds.

Authors:  Gary A Fielding; Amit Bandyopadhyay; Susmita Bose
Journal:  Dent Mater       Date:  2011-11-01       Impact factor: 5.304

2.  Stimulation of glucose transport in osteoblastic cells by parathyroid hormone and insulin-like growth factor I.

Authors:  E Zoidis; C Ghirlanda-Keller; C Schmid
Journal:  Mol Cell Biochem       Date:  2010-11-13       Impact factor: 3.396

3.  The Important Role of Osteoblasts and Citrate Production in Bone Formation: "Osteoblast Citration" as a New Concept for an Old Relationship.

Authors:  Leslie C Costello; Renty B Franklin; Mark A Reynolds; Meena Chellaiah
Journal:  Open Bone J       Date:  2012

4.  Bone mineralization in children with Wilson's disease.

Authors:  Ahmet Cetinkaya; Hasan Ozen; Aysel Yüce; Inci Nur Saltık-Temizel; Hülya Demir; Figen Gürakan
Journal:  Indian J Gastroenterol       Date:  2014-05-25

5.  Preservation and promotion of bone formation in the mandible as a response to a novel calcium-phosphate based biomaterial in mineral deficiency induced low bone mass male versus female rats.

Authors:  Kritika Srinivasan; Diana P Naula; Dindo Q Mijares; Malvin N Janal; Racquel Z LeGeros; Yu Zhang
Journal:  J Biomed Mater Res A       Date:  2016-03-11       Impact factor: 4.396

6.  Effect of supplementary zinc on orthodontic tooth movement in a rat model.

Authors:  Ahmad Akhoundi Mohammad Sadegh; Ghazanfari Rezvaneh; Etemad-Moghadam Shahroo; Alaeddini Mojgan; Khorshidian Azam; Rabbani Shahram; Shamshiri Ahmad Reza; Momeni Nafiseh; Mohammad Sadegh Ahmad Akhoundi
Journal:  Dental Press J Orthod       Date:  2016 Mar-Apr

7.  Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.

Authors:  Masayoshi Yamaguchi; M Neale Weitzmann
Journal:  Mol Cell Biochem       Date:  2011-05-01       Impact factor: 3.396

Review 8.  The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2016-08-30       Impact factor: 3.396

9.  Potentiating bisphosphonate-based coordination complexes to treat osteolytic metastases.

Authors:  Gabriel Quiñones Vélez; Lesly Carmona-Sarabia; Waldemar A Rodríguez-Silva; Alondra A Rivera Raíces; Lorraine Feliciano Cruz; Tony Hu; Esther Peterson; Vilmalí López-Mejías
Journal:  J Mater Chem B       Date:  2020-03-11       Impact factor: 6.331

10.  Zinc Supplementation Increases Procollagen Type 1 Amino-Terminal Propeptide in Premenarcheal Girls: A Randomized Controlled Trial.

Authors:  Paige K Berger; Norman K Pollock; Emma M Laing; Valerie Chertin; Paul J Bernard; Arthur Grider; Sue A Shapses; Ke-Hong Ding; Carlos M Isales; Richard D Lewis
Journal:  J Nutr       Date:  2015-10-21       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.